Low use of condom and high STI incidence among men who have sex with men in PrEP programs.

Autor: Oskar Ayerdi Aguirrebengoa, Mar Vera García, Daniel Arias Ramírez, Natalia Gil García, Teresa Puerta López, Petunia Clavo Escribano, Juan Ballesteros Martín, Clara Lejarraga Cañas, Nuria Fernandez Piñeiro, Manuel Enrique Fuentes Ferrer, Mónica García Lotero, Estefanía Hurtado Gallegos, Montserrat Raposo Utrilla, Vicente Estrada Pérez, Jorge Del Romero Guerrero, Carmen Rodríguez Martín

Publikováno v: PLoS ONE, Vol 16, Iss 2, p e0245925 (2021)

ObjectiveSince the recent introduction of preexposure prophylaxis (PrEP), several studies have reported a decrease in the use of condoms and a rise in STIs among users. This rise in risk behavior associated with the advent of PrEP is known as "risk c

Externí odkaz: https://doaj.org/article/0221a7539a354c58bc56773372f4fc08

Life Expectancy of People with HIV on Antiretroviral Therapy in Spain

Autor: Inma Jarrin, Marta Rava, Jorge del Romero Raposo, Antonio Rivero, Jorge del Romero Guerrero, María de Lagarde, Javier Martínez-Sanz, Gemma Navarro, David Dalmau, José Ramón Blanco, Ana Koerting, Javier Gomez Castellá, Julia del Amo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::41065739c6cffbb31f8f8df4a4325d44
https://doi.org/10.2139/ssrn.4445177

Atypical urethritis and proctitis in a heterosexual couple

Autor: Jorge A. Pérez-García, Mar Vera-García, Rocío Arriaza-Rubio, Jorge Del Romero-Guerrero

Publikováno v: Enfermedades infecciosas y microbiologia clinica (English ed.). 41:305-306

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1dc27f91410610b3a685d1d9a9e69cd2
https://doi.org/10.1016/j.eimce.2022.12.001

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

Autor: Onyema Ogbuagu, Peter J Ruane, Daniel Podzamczer, Laura C Salazar, Keith Henry, David M Asmuth, David Wohl, Richard Gilson, Yongwu Shao, Ramin Ebrahimi, Stephanie Cox, Alexander Kintu, Christoph Carter, Moupali Das, Jared M Baeten, Diana M Brainard, Gary Whitlock, Jason M Brunetta, Gitte Kronborg, Christoph D Spinner, Andrea Antinori, Vanessa Apea, David Asmuth, Ann Avery, Paul Benson, Colm Bergin, Mezgebe Berhe, Indira Brar, Cynthia Brinson, Jason Brunetta, Jeffrey Burack, Thomas Campbell, Michelle Cespedes, Amanda Clarke, Megan Coleman, Josep Coll, Manuel Crespo Casal, Catherine Creticos, Gordon Crofoot, Frederick Cruickshank, Eric Cua, Eric Daar, Joseph de Wet, Edwin DeJesus, Jorge Del Romero Guerrero, William Dinges, Susanne Doblecki-Lewis, Taylor Donovan, Olamide Dosekun, Jason Flamm, Joel Gallant, Jan Gerstoft, Jay Gladstein, Robert Grant, Robert Grossberg, Bernhard Haas, Jason Halperin, W. David Hardy, Charles Hare, Shawn Hassler, Richard Hengel, William Henry, Theo Hodge, Sybil Hosek, Christopher Hurt, Michelle Iandiorio, Heiko Jessen, Stephen Kegg, Gabriele Knecht, Ivanka Krznaric, Anthony LaMarca, Carsten Schade Larsen, Olav Ditlevsen Larsen, Adriano Lazzarin, Clifford Leen, Christopher Lucasti, Patrick Mallon, Sharon Mannheimer, Martin Markowitz, Claudia Martorell, Kenneth Mayer, Anthony Mills, Jean-Michel Molina, Sheldon Morris, Karam Mounzer, Nneka Nwokolo, Olayemi Osiyemi, Andrew Petroll, Patrick Philibert, John Phoenix, Gilles Pialoux, Frank Post, Maria Prins, Moti Ramgopal, Bruce Rashbaum, Iain Reeves, Gary Richmond, Armin Rieger, Peter Ruane, Laura Salazar, Anthony Scarsella, Gabriel Schembri, Mia Scott, Peter Shalit, Gary Sinclair, Magdalena Sobieszczyk, Christoph Spinner, Jeffrey Stephens, Jason Szabo, Stephen Taylor, Melanie Thompson, Cecile Tremblay, Benoit Trottier, Gene Voskuhl, Barbara Wade, Kimberly Workowski, Sigal Yawetz, Benjamin Young

Publikováno v: The Lancet HIV, 8(7), e397-e407. Elsevier Limited
DISCOVER study team 2021, ' Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis : week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial ', The Lancet HIV, vol. 8, no. 7, pp. e397-e407 . https://doi.org/10.1016/S2352-3018(21)00071-0

Summary Background In DISCOVER, a multinational, randomised controlled trial, emtricitabine and tenofovir alafenamide compared with emtricitabine and tenofovir disoproxil fumarate showed non-inferior efficacy for HIV prevention and improved bone mine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::303b5922ad83d78a448781b8c096428c
https://doi.org/10.1016/s2352-3018(21)00071-0

¿Sigue siendo útil la microscopia de campo oscuro en el diagnóstico de la sífilis primaria en el siglo XXI?

Autor: Clara Lejarraga-Cañas, Estela Tello-Romero, Blanca Menéndez-Prieto, Oskar Ayerdi-Aguirrebengoa, Jorge del Romero-Guerrero, Carmen Rodríguez-Martín

Publikováno v: Enfermedades Infecciosas y Microbiología Clínica. 40:32-34

Resumen Introduccion La serologia luetica en la sifilis primaria puede ser negativa los primeros 5-15 dias. El objetivo de este trabajo fue evaluar los beneficios de incluir la microscopia de campo oscuro (MCO) en el algoritmo diagnostico de la sifil

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::47f23473190035fd747d65e68b338eea
https://doi.org/10.1016/j.eimc.2020.09.005